Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-23

Clinical Trial Update: A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating Hepalatide for injection in patients with chronic hepatitis D, with the study listed as ACTIVE_NOT_RECRUI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepalatide for Injection

Snippet

Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. | Conditions: Hepatitis D | Phase 2 | Status: ACTIVE_NOT_RECRUITING